Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 27% ± 3% | |
glutamatergic neuron | 3 studies | 23% ± 3% | |
transit amplifying cell | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2146.63 | 966 / 966 | 100% | 25.70 | 527 / 527 |
skin | 100% | 2865.61 | 1809 / 1809 | 100% | 33.32 | 472 / 472 |
stomach | 100% | 1325.05 | 359 / 359 | 100% | 24.80 | 286 / 286 |
uterus | 100% | 2161.18 | 170 / 170 | 100% | 30.09 | 459 / 459 |
bladder | 100% | 1602.57 | 21 / 21 | 100% | 24.65 | 503 / 504 |
ovary | 100% | 1719.87 | 180 / 180 | 100% | 27.40 | 429 / 430 |
breast | 100% | 2433.37 | 459 / 459 | 100% | 30.03 | 1115 / 1118 |
lung | 100% | 2341.08 | 578 / 578 | 100% | 24.17 | 1151 / 1155 |
esophagus | 100% | 1790.95 | 1445 / 1445 | 99% | 25.80 | 182 / 183 |
thymus | 100% | 2055.49 | 653 / 653 | 99% | 16.35 | 600 / 605 |
pancreas | 99% | 1010.90 | 324 / 328 | 99% | 17.62 | 176 / 178 |
kidney | 100% | 1333.75 | 89 / 89 | 97% | 16.04 | 875 / 901 |
brain | 96% | 958.40 | 2538 / 2642 | 99% | 16.03 | 699 / 705 |
prostate | 100% | 1710.64 | 245 / 245 | 93% | 12.52 | 469 / 502 |
adrenal gland | 100% | 1337.40 | 258 / 258 | 92% | 8.94 | 211 / 230 |
liver | 99% | 707.70 | 224 / 226 | 67% | 6.84 | 271 / 406 |
adipose | 100% | 2075.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 14.68 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.43 | 29 / 29 |
spleen | 100% | 3933.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.55 | 1 / 1 |
blood vessel | 100% | 1168.36 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 997.74 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2612.21 | 908 / 929 | 0% | 0 | 0 / 0 |
muscle | 77% | 436.65 | 618 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0006974 | Biological process | DNA damage response |
GO_0016485 | Biological process | protein processing |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0001554 | Biological process | luteolysis |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0006915 | Biological process | apoptotic process |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_0003407 | Biological process | neural retina development |
GO_0005730 | Cellular component | nucleolus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1905369 | Cellular component | endopeptidase complex |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0097200 | Molecular function | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO_0097199 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CASP2 |
Protein name | Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12] Caspase 2 apoptosis-related cysteine peptidase isoform 1 Caspase 2 apoptosis-related cysteine peptidase isoform 2 Caspase 2 |
Synonyms | ICH1 NEDD2 |
Description | FUNCTION: Involved in the activation cascade of caspases responsible for apoptosis execution. Might function by either activating some proteins required for cell death or inactivating proteins necessary for cell survival . Associates with PIDD1 and CRADD to form the PIDDosome, a complex that activates CASP2 and triggers apoptosis in response to genotoxic stress . . |
Accessions | P42575 A0A087WYM1 A0A0S2Z3H1 ENST00000619992.4 C9JRR9 ENST00000350623.7 A0A0S2Z3I0 ENST00000310447.10 [P42575-1] ENST00000392925.6 |